Abstract
During a review of the unselected diabetic patients with acute MI at our institution in the mid 80’s, we found that 22% of our patients had diabetes, and an even more striking finding was that more than 50% have died within one year1. One can argue that this was before the introduction of modern treatment strategies but even recent data confirm an almost doubled 35-day mortality rate in diabetic patients who have suffered an acute MI compared to non-diabetics2. After that we planned for the DIGAMI study which was completed in 1994. The results of this study have been published elsewhere. 3,4,5
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988; 9: 256–64
Woodfield SL, Lundergan CF, Reiner JS, et al. Angiographie findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996;28:1661–1669
Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. A randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: Effects on one year mortality. J Am Coll Cardiol 1995; 26:57–65
Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J 1996; In press
Malmberg K. Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. British Medical Journal 1997; 314: 1512–1515
Stone P, Muller J, Hartwell T, Yourk B, Rutherford J, Parker C, Turi Z, Strauss W, Willerson J, Robertson T. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989; 14: 49–57
Jaffe A, Spadaro J, Schechtman K, Roberts R, Geltman E, Sobel B. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984; 108: 31–37
Karlson BW, Herlitz J, Hjalmarson A. Prognosis of acute myocardial infarction in diabetic and non-diabetic patients. Diabet Med 1993; 10: 449–54
Barbash GI, White HD, Modan M, Van der werf WF. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol 1993; 22: 707–713
Fath-Ordoubadi F, Beatt K. Glucose-Insulin-Potassium therapy for treatment of acute myocardial infarction. An overview of randomized placebo controlled trials. Circulation 1997; 96: 1152–1156.
Diaz R, Paolasso EA, Piegas LS et al. Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial. Circulation 1998; 98: 2227–2234.
Glucose-insulin-potassium in acute myocardial infarction. The time has come for a large, prospective trial. Apstein CS, Taegtmeyer H. Circulation 1997; 96: 1074–1077.
Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycemic control. Diabet Med 1993; 10: 27–32
Davi G, Catalan I, Avema M, Notarbartolo A, Sartrano A, Ciaboattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type 2 diabetes mellitus. New Engl J Med 1990; 322:1769–1774
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Malmberg, K., Norhammar, A., Rydén, L. (2001). Insulin Treatment Post Myocardial Infarction: The Digami Study. In: Angel, A., Dhalla, N., Pierce, G., Singal, P. (eds) Diabetes and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 498. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1321-6_35
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1321-6_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5496-3
Online ISBN: 978-1-4615-1321-6
eBook Packages: Springer Book Archive